Healthy Subjects
Conditions
Brief summary
Many epidemiological and clinical studies have suggested the negative effect of oxidative stress ( = attack of cell components by free radicals) on the cardiovascular risk, notably in patients with metabolic syndrome, insulin resistance, diabetes or obesity and smokers. Polyphenols, notably those present in red grapes, have a certain antioxidant effect. Dietary supplementation with polyphenols in high-risk patients could diminish the harmful consequences of oxidative stress. The aim of this study is to show that the daily consumption of grape juice rich in polyphenols R@isol , has a positive impact on the oxidation/antioxidation balance in healthy volunteers.
Interventions
OTHERGrape juice R@isol
OTHERCommercially-available grape juice
Sponsors
Centre Hospitalier Universitaire Dijon
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
DOUBLE
Eligibility
Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes
Inclusion criteria
* Subjects aged from 18 to 50 years * Men and women * With national health insurance cover * With a Body Mass Index between 18.5 and 27.9 * Who have given their written informed consent to take part in the study.
Exclusion criteria
* Subjects unable to understand the nature and aims of the study and/or those who have difficulty communicating with the investigator. * Adults under ward of court. * Those in custody following a decision of the court or the administration. * Subjects with a risk of a major change in their diet during the trial. * Those who drink more than 5 cups of tea or coffee a day. * Those who consumed more than 25 grammes of alcohol a day, every day of the year preceding the inclusion visit. * Those who present a history of or current use of psycho-active substances (drugs such as cocain, morphine, heroin...). * Subjects currently in a period of exclusion relative to another research protocol or for whom the annual cummulation of payments for participation in biomedical research has reached the annual ceiling. * Presence of any treated chronic disease, and any acute disease within the 4 weeks preceding the inclusion and randomisation visit. * Persons with diabetes treated with insulin or oral antidiabetics. * Subjects on lipid-lowering therapy and/or on antioxidants (such as vitamin E, vitamin C, selenium, ß-carotene, Zinc) in the month preceding inclusion. * Subjects taking multivitamin supplements in the month preceding inclusion. * Pregnant or breast-feeding women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measurement of plasma levels of hydroxyoctadecadienoic acid | At inclusion, 15 days and 3 months. |
Secondary
| Measure | Time frame |
|---|---|
| Measurement of endothelial function | At the inclusion and 3 month |
Countries
France
Outcome results
None listed